Schistosomiasis in the first 1000 days

Area of Science:

• Parasitology
• Public Health
• Developmental Pediatrics

Background:

• The first 1000 days (conception to age 2) are critical for development, with infections having lifelong impacts.
• Schistosomiasis poses a significant burden on women of reproductive age and young children, often overlooked in mass drug administration.
• Early-life schistosomiasis infections can lead to accumulated disease burden later in life, impacting adolescent health.

Purpose of the Study:

• To evaluate the adverse effects of early schistosomiasis on birth outcomes, child growth, and development.
• To advocate for expanded public health interventions targeting women of reproductive age and preschool-age children for schistosomiasis.
• To highlight the need for research into pre-conception treatment strategies for schistosomiasis to optimize lifelong maternal and child health.

Main Methods:

• Review of existing evidence on the impact of early schistosomiasis on health outcomes.
• Analysis of the disease burden and transmission dynamics in vulnerable populations.
• Discussion of public health strategies and research gaps.

Main Results:

• Early exposure to schistosomes during pregnancy can negatively affect infant immune development.
• Schistosomiasis infections acquired in early infancy contribute to the high disease burden observed in adolescents.
• Current mass drug administration programs often neglect women of reproductive age and young children, missing opportunities for early intervention.

Conclusions:

• Early schistosomiasis infections have detrimental effects on birth, growth, and development, with lifelong consequences.
• Expanding public health interventions to include women of reproductive age and preschool-age children is essential for schistosomiasis control.
• Further research is needed to explore the benefits of pre-conception schistosomiasis treatment for maximizing health across the life course.